SUBSEQUENT EVENTS	9 Months Ended
Sep. 30, 2021
SUBSEQUENT EVENTS
Note I - SUBSEQUENT EVENTS	NOTE I – SUBSEQUENT EVENTS PRIVATE PLACEMENT – OCTOBER 2021 On October 18, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with a non-affiliated, accredited investor (the “Investor”), pursuant to which the Company has agreed to issue and sell to the Investor in a private placement (the “Private Placement”), 2,500,000 shares of the Company’s common stock, par value $0.01 per share (“Common Share”), at a price per Common Share of $0.04 (the “Purchase Price”) for gross proceeds of $100,000. The Company received net proceeds of $100,000 from the Private Placement as there were no expenses related to the Private Placement. The Company did not utilize a placement agent for the Private Placement. The Company will use the proceeds for working capital and general corporate purposes. The Company does not intend to register the Common Shares issued under the Private Placement; rather the Common Shares issued will be subject to the holding period requirements and other conditions of Rule 144. The Purchase Agreement contains customary representations, warranties and covenants made solely for the benefit of the parties to the Purchase Agreement. A Current Report on Form 8-K was filed on October 25, 2021 and the full text of the SPA was included as Exhibit 4.28 to the Form 8-K. NOVEMBER 2020 TERM LOAN - EXTENSION On November 4, 2021, we entered into a twelve-month Extension Agreement (the “Extension”) with the shareholder. Under the Extension, the principal in the amount of $50,000 is now due on November 4, 2022. The interest rate and all other terms of the note remain unchanged under the Extension. The interest payment due to the shareholder on November 4, 2021 was paid as required with the next interest payment being due on February 4, 2022.

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2021

NOTE I – SUBSEQUENT EVENTS

PRIVATE PLACEMENT – OCTOBER 2021

On October 18, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with a non-affiliated, accredited investor (the “Investor”), pursuant to which the Company has agreed to issue and sell to the Investor in a private placement (the “Private Placement”), 2,500,000 shares of the Company’s common stock, par value $0.01 per share (“Common Share”), at a price per Common Share of $0.04 (the “Purchase Price”) for gross proceeds of $100,000.

The Company received net proceeds of $100,000 from the Private Placement as there were no expenses related to the Private Placement. The Company did not utilize a placement agent for the Private Placement. The Company will use the proceeds for working capital and general corporate purposes.

The Company does not intend to register the Common Shares issued under the Private Placement; rather the Common Shares issued will be subject to the holding period requirements and other conditions of Rule 144.

The Purchase Agreement contains customary representations, warranties and covenants made solely for the benefit of the parties to the Purchase Agreement. A Current Report on Form 8-K was filed on October 25, 2021 and the full text of the SPA was included as Exhibit 4.28 to the Form 8-K.

NOVEMBER 2020 TERM LOAN - EXTENSION

On November 4, 2021, we entered into a twelve-month Extension Agreement (the “Extension”) with the shareholder. Under the Extension, the principal in the amount of $50,000 is now due on November 4, 2022. The interest rate and all other terms of the note remain unchanged under the Extension. The interest payment due to the shareholder on November 4, 2021 was paid as required with the next interest payment being due on February 4, 2022.